LOS ANGELES--(BUSINESS WIRE)--Xtraction Services Holding Corp., (“Xtraction Services”, "XS" or the "Company") (CSE:XS) (OTCQB: XSHLF), a specialty finance company engaged in equipment leasing in the United States, announced today two new lease agreements with Carolina Botanical Development LLC (“CBD LLC”), a USDA organic certified cannabidiol extraction company based in South Carolina, United States.
CBD LLC is an existing customer with two existing lease agreements entered into March and April 2019. The company has made all contracted payments from its existing leases and now requires additional equipment, which XS is pleased to support. The new leases are short-term for $66,000 with a 120-day term and $50,000 with a 90-day term. The equipment was sourced through XS’ Preferred Vendors and range from solvent recovery to remediation systems.
David Kivitz, Chief Executive Officer of XS commented, “We are very pleased to be able to provide additional leasing solutions for CBD LLC and executed on this transaction in a very short manner. The new leases will allow CBD to expand its production capabilities and increase manufacturing capacity and downstream capability. As our customers continue to grow, we will be there to support them with their equipment needs.”
About Xtraction Services
Founded in 2017, XS specializes in providing equipment leasing solutions in the United States to owner/operators of cannabis and hemp companies, including cultivators, oil processors, manufacturers, testing laboratories, among others. In addition, XS provides a full range of consulting services including equipment selection and procurement, through its network of preferred vendor partnerships with original equipment manufacturers and equipment distributors. This powerful dynamic provides an end-to-end solution for customers, which results in recurring revenues, strong profit margins, and a proven business model for XS stakeholders.
Neither the Canadian Securities Exchange nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release.